Compare

Vita Coco Company, Inc. vs Keurig Dr Pepper Inc. vs SRX Global Inc. vs Arcadia Biosciences, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearVita Coco Company, Inc.
COCO
Keurig Dr Pepper Inc.
KDP
SRX Global Inc.
SRXH
Arcadia Biosciences, Inc.
RKDA
Year ended2025-12-312025-12-312025-09-302025-12-31
Revenue$609.78M$16.60B$6.53M$4.86M
Revenue growth (YoY)+18.2%+8.2%n/a-3.7%
Gross margin36.5%54.2%23.4%36.2% (computed)
Operating margin13.5%21.5%-174.6%-51.5%
Net margin11.7%12.5%-688.8%-48.1%
Net income$71.32M$2.08B-$45.01M-$2.34M
EPS (Diluted)$1.19$1.53-$2.13-$1.71
Operating cash flow$47.17M$1.99B-$8.14M-$4.74M
Free cash flow$39.02M$1.50Bn/a-$4.74M
Cash & equivalents$196.87M$1.03B$1.31M$259.0K
Total assets$461.16M$55.46B$8.40M$6.55M
Total liabilities$129.62M$29.94B$8.00M$2.41M
Shareholders' equity$331.54M$25.52B$407.0K$4.14M
Return on year-end equity21.5%8.1%n/m-56.5%
Shares outstanding57.08M1.36B24.92M1.37M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearVita Coco Company, Inc.Keurig Dr Pepper Inc.SRX Global Inc.Arcadia Biosciences, Inc.
Latest$609.78M
Ended 2025-12-31
$16.60B
Ended 2025-12-31
$6.53M
Ended 2025-09-30
$4.86M
Ended 2025-12-31
1 year earlier$516.01M
Ended 2024-12-31
$15.35B
Ended 2024-12-31
n/a$5.04M
Ended 2024-12-31
2 years earlier$493.61M
Ended 2023-12-31
$14.81B
Ended 2023-12-31
n/a$4.45M
Ended 2023-12-31
3 years earlier$427.79M
Ended 2022-12-31
$14.06B
Ended 2022-12-31
n/a$7.42M
Ended 2022-12-31
4 years earlier$379.51M
Ended 2021-12-31
$12.68B
Ended 2021-12-31
n/a$6.78M
Ended 2021-12-31